August 17, 2022
Via: Healthcare DiveOn Tuesday, President Joe Biden signed a $740 billion package into law enacting some of the biggest changes to U.S. healthcare since the passage of the Affordable Care Act over a decade ago. The Inflation Reduction Act allows Medicare to […]
January 27, 2020
Via: HITECH AnswersThe call for healthcare price transparency is growing louder, with seemingly obvious benefits. Patients, knowing what they’ll owe, can make informed decisions about their care and how they’ll pay for it. Providers can build trusting relationships and increase the likelihood […]
January 6, 2020
Via: ForbesLate last month, the Trump administration released a plan that would green-light the importation of certain drugs from Canada and potentially other foreign countries. The administration’s proposal comes on the heels of legislative pushes by Republican Governor Ron DeSantis of […]
October 14, 2019
Via: The Medical NewsDrugmakers fought hard against California’s groundbreaking drug price transparency law, passed in 2017. Now, state health officials have released their first report on the price hikes those drug companies sought to shield. Pharmaceutical companies raised the “wholesale acquisition cost” of […]
July 15, 2019
Via: ForbesLast week, President Trump declared his administration would soon issue an executive order mandating a so-called “favored nations” policy in which U.S. government (presumably, Medicare and Medicaid) payments for drugs would be capped at the lowest price paid by a […]
June 20, 2019
Via: ForbesThe crisis in drug pricing has reached global proportions. According to a recent article in The Economist, “THESE DAYS it is hard to find a government that is not struggling with the high price of medicines. …[T]he unaffordability of medicines…[is […]
June 20, 2019
Via: CNBCThe presidential hopefuls aren’t the only ones eyeing health care issues for 2020. Large employers are putting together benefit plans for next year, and they are expecting the rise in employee health costs to hit a four-year high, in part, […]
May 9, 2019
Via: CNBCThe Trump administration wants to shame pharmaceutical companies into lowering prescription drug prices, Health and Human Services Secretary Alex Azar told CNBC in an interview Thursday. Pharmaceutical companies will be required to disclose the list price of their prescription medicines […]
May 8, 2019
Via: The Medical NewsIf there’s one area of health care where Republicans and Democrats might strike a deal, it’s prescription drugs. President Donald Trump has floated a plan to cut drug prices. Democratic and Republican ideas abound in Congress, where lawmakers have put […]
March 27, 2019
Via: ForbesIn the battle over the pricing of new drugs, manufacturers and payers have sought to come up with novel approaches to pricing that can be tolerated by both parties. One such approach has been to provide a type of money-back […]
Innovation, News, Patient Experience
November 26, 2018
Via: ForbesThe Trump Administration has not been shy about being critical of drug prices, transparency, and other issues it sees as plaguing the prescription drug market. One can say that this Administration has been more proactive in this area than any […]
October 15, 2018
Via: CNBCMajor drugmakers will soon include price information in television advertisements, conceding to the Trump administration but not as far as the administration may have hoped. Starting April 15, 2019, members of the Pharmaceutical Research and Manufacturers of America trade group […]
July 19, 2018
Via: ForbesTwo years ago on this Forbes channel, Scott Gottlieb suggested that Donald Trump’s proposal to import inexpensive prescription drugs from overseas would “offer consumers little relief” from rising drug prices. But that was before Trump became President, named Gottlieb commissioner […]
June 27, 2018
Via: CNBCAmericans continue to suffer the highest prescription drug costs of anyone in the world. One in four are unable to fill prescriptions due to high prices, according to a recent poll. And even though drug prices tripled over the last […]
May 18, 2018
Via: The Medical NewsThis week, Vermont passed a first-in-the-nation law that would facilitate the state’s importation of prescription drugs wholesale from Canada. It represents the state’s effort to tackle head-on the issue of constantly climbing drug prices. Other states, including Louisiana and Utah, […]
May 15, 2018
Via: CNBCU.S. allies’ drug pricing strategies are not sustainable for long-term success, and that’s adversely leading to higher prescription costs at home and abroad, FDA Commissioner Dr. Scott Gottlieb told CNBC on Tuesday. Europeans “do underpay relative to us for branded […]
March 21, 2018
Via: CNBCDrug prices are still climbing despite calls to lower them, Axios reports. President Donald Trump has repeatedly chastised the pharmaceutical industry, even accusing them of “getting away with murder.” But since he took office, drugmakers have hiked list prices on […]
January 19, 2018
Via: CNBCDonald Trump raged against the pharmaceutical industry as a candidate. He accused drug companies of “getting away with murder” as president-elect. But he hasn’t done too much to tackle prices as president — yet. Trump has occasionally criticized high drug […]
June 15, 2017
Via: FierceHealthcareA bipartisan Senate health committee held the first of three hearings on the rising costs of prescription drugs but didn’t get very far. In many ways it became a gripe session for Democrats over their Republican counterparts’ closed-door session and […]
March 8, 2017
Via: CNBCPresident Donald Trump’s claims that he will bring drug prices “way down” sent health-care stocks tumbling Tuesday morning. On Tuesday, pharmaceutical stocks were the biggest laggards in the S&P 500 for much of the morning, with the health-care sector closing […]